Small cell lung cancer patients treated with immune checkpoint inhibitor: a systematic literature review of treatment efficacy, safety and quality of life-Reference-Cited by-同舟云学术

Small cell lung cancer patients treated with immune checkpoint inhibitor: a systematic literature review of treatment efficacy, safety and quality of life

Published:2022-05-31 Issue:8 Volume:38 Page:1361-1368
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Korde Rasika¹,Veluswamy Rajwanth²³⁴,Allaire Jason C.⁵⁶,Barnes Gisoo⁷

Affiliation:

1. School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA

2. Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, NY, USA

3. Tisch Cancer Institute and Icahn School of Medicine, Center for Thoracic Oncology, Mount Sinai, NY, USA

4. Icahn School of Medicine at Mount Sinai, Institute for Translational Epidemiology, Mount Sinai, NY, USA

5. Health Economics and Patient Outcomes, Generativity Health Economics and Outcomes Research, Durham, USA

6. Department of Psychology, North Carolina State University, Raleigh, NC, USA

7. BeiGene, Ltd., Health Economics and Outcomes Research, Emeryville, CA, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2078101

Reference32 articles.

1. International Agency for Research on Cancer: Global Cancer Observatory [accessed 2021 Dec 1]. Available from: https://gco.iarc.fr/

2. Orphanet: The portal for rare diseases and orphan drugs [accessed 2021 Dec 1]. Available from: https://www.orpha.net/consor/cgi-bin/index.php?lng=EN

3. Immune checkpoint inhibitors in small cell lung cancer

4. Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer;Respiratory Medicine and Research;2024-11

2. Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy;Clinical and Translational Oncology;2024-09-06

3. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer;Molecular Therapy: Oncology;2024-03

4. Significant Palliative Benefits Following Therapy With Mifepristone for Advanced Treatment Resistant Small Cell Lung Cancer;Anticancer Research;2024-02

5. The Sweet and Sour of Glycan Targeting in Cancer;Interdisciplinary Cancer Research;2024